CS logo
small CS logo
ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing

Dingolfing, Germany
Doctor in Dingolfing, Bavaria
Griesgasse 18, 84130 Dingolfing

About ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing


During the past decade, ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing" #1 collaborator was "Optimapharm" with 2 trials as a collaborator, "University of Ulm" with 2 trials as a collaborator, "X-act Cologne Clinical Research GmbH" with 2 trials as a collaborator, "Zentrum für Klinische Studien Ulm" with 2 trials as a collaborator and "Bayer Healthcare LTD" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

Clinical Trials Conditions at ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing


According to Clinical.Site data, the most researched conditions in "ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing" are "Marginal Zone Lymphoma" (2 trials). Many other conditions were trialed in "ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing" in a lesser frequency.

Clinical Trials Intervention Types at ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing


Most popular intervention types in "ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Copanlisib" (1 trials), "Obinutuzumab" (1 trials) and "Rituximab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing


The vast majority of trials in "ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing" are 2 trials for "All" genders.

Clinical Trials Status at ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing


Currently, there are NaN active trials in "ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in ÜBAG MVZ Dr. Vehling-Kaiser GmbH Dingolfing, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".